Please use this identifier to cite or link to this item:
Title: Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
Citation: BRITISH JOURNAL OF CANCER, v.108, n.6, p.1316-1323, 2013
Abstract: Background: The prognostic/predictive value of potential vascular endothelial growth factor (VEGF) signalling biomarkers was evaluated retrospectively using samples from two randomized Phase III studies (HORIZON II and III) investigating cediranib in metastatic colorectal cancer (mCRC). Methods: Baseline levels of VEGF, soluble VEGF receptor-2 (sVEGFR-2) and carcinoembryonic antigen (CEA) were measured in plasma/serum samples collected from patients participating in HORIZON II (n = 860; FOLFOX/XELOX plus cediranib 20 mg (n = 502) or placebo (n = 358)) and HORIZON III (n = 1422; mFOLFOX6 plus cediranib 20 mg (n = 709) or bevacizumab (n = 713)). Median biomarker baseline levels determined cutoff values for the patient subgroups. Results: Baseline data were available for 88-97% of patients/study (>2000 patients). In both the studies, high baseline VEGF and CEA were associated with worse outcomes for progression-free survival (PFS) and overall survival (OS) independent of treatment (HORIZON II OS: VEGF, hazard ratio (HR) = 1.35 (95% confidence interval (CI): 1.12-1.63); CEA, HR = 1.63 (1.36-1.96); HORIZON III OS: VEGF, HR = 1.32 (1.12-1.54); CEA, HR = 1.50 (1.29-1.76)). sVEGFR-2 was not prognostic for PFS/OS. Baseline VEGF and CEA were not predictive for PFS/OS outcome to cediranib treatment; low sVEGFR-2 was associated with a trend towards improved cediranib effect in HORIZON II. Conclusion: Baseline VEGF and CEA levels were treatment-independent prognostic biomarkers for PFS and OS in both the studies.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/InRad
Instituto de Radiologia - HC/InRad

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)271.15 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.